Clinical Trial Update: Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy [Phase 4]

View source ↗

Summary

Phase 4 study comparing intrapatient urinary radioactivity between Piflufolastat F-18 and Flotufolastat F-18 PET imaging in men with low PSA recurrence of prost…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Flotufolastat F-18 (flotufolastat F-18)
• Piflufolastat F-18 (piflufolastat F-18)

Snippet

Sponsor: Blue Earth Diagnostics | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED